Skip to Content
Merck
CN
  • X-ray induced photodynamic therapy (PDT) with a mitochondria-targeted liposome delivery system.

X-ray induced photodynamic therapy (PDT) with a mitochondria-targeted liposome delivery system.

Journal of nanobiotechnology (2020-06-12)
Xuefan Gu, Chao Shen, Hua Li, Ewa M Goldys, Wei Deng
ABSTRACT

In this study, we constructed multifunctional liposomes with preferentially mitochondria-targeted feature and gold nanoparticles-assisted synergistic photodynamic therapy. We systemically investigated the in vitro X-ray triggered PDT effect of these liposomes on HCT 116 cells including the levels of singlet oxygen, mitochondrial membrane potential, cell apoptosis/necrosis and the expression of apoptosis-related proteins. The results corroborated that synchronous action of PDT and X-ray radiation enhance the generation of cytotoxic reactive oxygen species produced from the engineered liposomes, causing mitochondrial dysfunction and increasing the levels of apoptosis.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Verteporfin, ≥94% (HPLC)
Sigma-Aldrich
Methanol, suitable for HPLC, ≥99.9%
Sigma-Aldrich
Chloroform, contains 100-200 ppm amylenes as stabilizer, ≥99.5%
Sigma-Aldrich
(4-Carboxybutyl)triphenylphosphonium bromide, 98%
Sigma-Aldrich
N-Hydroxysuccinimide, 98%
Sigma-Aldrich
N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride, commercial grade, powder
Sigma-Aldrich
McCoy′s 5A Medium, Modified, with sodium bicarbonate, without L-glutamine, liquid, sterile-filtered, suitable for cell culture
Sigma-Aldrich
MES, low moisture content, ≥99% (titration)
Sigma-Aldrich
1,2-Dioleoyl-sn-glycero-3-phosphocholine, lyophilized powder
Sigma-Aldrich
MES solution, BioUltra, Molecular Biology, 0.5 M in H2O
Sigma-Aldrich
Dimethyl sulfoxide, ACS reagent, ≥99.9%